Soligenix
SNGX
#10271
Rank
โ‚ฌ10.46 M
Marketcap
1,04ย โ‚ฌ
Share price
-0.40%
Change (1 day)
-53.39%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2025 (TTM): -โ‚ฌ11.18 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚ฌ7.92 Million a decrease over its 2023 earnings that were of -โ‚ฌ6.44 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ11.18 Million41.17%
2024 -โ‚ฌ7.92 Million22.96%
2023 -โ‚ฌ6.44 Million-45.74%
2022 -โ‚ฌ11.87 Million11.88%
2021 -โ‚ฌ10.61 Million-32.37%
2020 -โ‚ฌ15.68 Million83.18%
2019 -โ‚ฌ8.56 Million11.57%
2018 -โ‚ฌ7.67 Million19.29%
2017 -โ‚ฌ6.43 Million33%
2016 -โ‚ฌ4.84 Million-19.7%
2015 -โ‚ฌ6.02 Million5.16%
2014 -โ‚ฌ5.73 Million
2010 -โ‚ฌ6.47 Million26.12%
2009 -โ‚ฌ5.13 Million75.1%
2008 -โ‚ฌ2.93 Million-45.38%
2007 -โ‚ฌ5.36 Million-22.84%
2006 -โ‚ฌ6.95 Million66.15%
2005 -โ‚ฌ4.18 Million-16.65%
2004 -โ‚ฌ5.02 Million13.28%
2003 -โ‚ฌ4.43 Million-11.88%
2002 -โ‚ฌ5.03 Million-59.44%
2001 -โ‚ฌ12.39 Million378.18%
2000 -โ‚ฌ2.59 Million-38.53%
1999 -โ‚ฌ4.22 Million-18.43%
1998 -โ‚ฌ5.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ27.42 B-262,014.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ10.03 B-95,920.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ7.70 B-73,673.72%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-โ‚ฌ15.38 Million 46.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-โ‚ฌ35.36 Million 237.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.50 B-14,426.25%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-โ‚ฌ2.34 Million-77.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.13 B-1,436.42%๐Ÿ‡บ๐Ÿ‡ธ USA